Young athletes may be more prone to sudden death than non-athletes; enhanced screening urged

November 11, 2001

ANAHEIM, Calif., Nov. 11 - Young competitive athletes are more than twice as likely to experience sudden death (SD) as their non-athletic counterparts, according to an Italian study presented today at the American Heart Association's Scientific Sessions 2001 conference. This is the first prospective, population-based study comparing the incidence of sudden death of athletes and non-athletes in the same population and geographic area.

This data shouldn't discourage young people from participating in sports; rather, it should point to the need for more extensive screening methods for young athletes, says study author Domenico Corrado, M.D., consultant of clinical cardiology and electrophysiology at the University of Padova Medical School in Padova, Italy.

"In young people, cardiovascular diseases that usually are silent account for a higher risk of sudden death during sports," he says. "Pre-participation screening is important in identifying the athletes affected by these potentially lethal conditions."

To establish the effect of sports activity on the risk of SD, researchers investigated the incidence of fatal events in the athletic and non-athletic populations, ages 12 to 35, in the Veneto region of Italy from 1979 to 1999. All athletes in Italy of these ages undergo mandatory sports screenings, including personal and family history and a 12-lead electrocardiogram (ECG).

Three hundred sudden deaths in young people were recorded during this period, representing 1 per 100,000 per year in this age group. Among athletes, the rate of sudden death was 2.3 per 100,000 compared with 0.9 per 100,000 for non-athletes. There were more deaths among non-athletes (245) versus athletes (55), but the non-athlete group is much larger than the athlete group, Corrado says. The estimated risk of sudden death was 2.5 times higher in athletes.

The relative risk of SD among athletes versus non-athletes was 1.95 for males and 2.02 for females.

The study also identified the conditions most likely to cause SD in younger athletes, including anomalous coronary artery origin (a congenital heart abnormality in the coronary artery) and arrhythmogenic right ventricular cardiomyopathy (a heart muscle disease that predisposes people to deadly irregular heart rhythms). The relative risk of sudden death due to anomalous origin of the coronary artery was 78.4 times higher in athletes than in non-athletes. The relative risk for sudden death due to arrhythmogenic right ventricular cardiomyopathy was 5.5 higher in athletes compared with non-athletes.

The researchers note that one of the major causes of SD in young athletes in the United States didn't show up as much in the Italian population - hypertrophic cardiomyopathy, an excessive thickening of the heart muscle. A U.S. study indicated that 36 percent of 158 athletes (median age 17) who died of sudden cardiac death from 1985 to 1995 had probable or definite hypertrophic cardiomyopathy. This discrepancy could be due to the Italian protocol for pre-participation sports screenings that includes an ECG, which identifies those at risk for hypertrophic cardiomyopathy, Corrado says.

Corrado believes the addition of the pre-participation ECG testing is beneficial for younger athletes because it is especially sensitive for identifying heart abnormalities.

American Heart Association spokesman Gerald Fletcher, M.D., says the study provides important new data, but an ECG has limited value in young people.

"In hypertrophic cardiomyopathy, the ECG may not reveal changes in 10 percent or more of cases and in those that do the changes may be unclear," says Fletcher.

The American Heart Association's position on pre-participation screening emphasizes a careful personal and family history and physical examination. If data suggests a potential cardiac problem, the physician may recommend further testing. That may include an ECG, echocardiogram or exercise stress testing, says Fletcher.
-end-
Other authors of the study are: Cristina Basso, M.D.; Giulio Rizzoli, M.D.; and Gaetano Thiene, M.D.

CONTACT:
For information Nov. 10 - 14 call:
Bridgette McNeill or Karen Hunter
at the Hilton Anaheim Hotel
(714) 251-5801

Abstract 1654

NR01-1351 (SS2001/Corrado)

American Heart Association

Related Heart Muscle Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

Heart muscle cells change their energy source during heart regeneration
Researchers from the Hubrecht Institute (KNAW) have found that the muscle cells in the heart of zebrafish change their metabolism during heart regeneration.

New study may have the reason why heart medication gives muscle pain
The McMaster research team found muscle cells treated with statins released the amino acid called glutamate at much higher levels than muscle cells that were untreated.

Vitamin E found to prevent muscle damage after heart attack
Early studies from scientists at the Baker Heart and Diabetes Institute in Australia and Jena University in Germany have found Vitamin E could be used to save the muscle from dying during a heart attack.

A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.

What is known -- and not known -- about heart muscle diseases in children
Cardiomyopathies (heart muscle diseases) in children are the focus of a new scientific statement from the American Heart Association that provides insight into the diagnosis and treatment of the diseases as well as identifying future research priorities.

Being overweight as a teen may be associated with higher risk of heart muscle disease in adulthood
The risk of developing cardiomyopathy, which often leads to heart failure, increased in adult Swedish men who were even mildly overweight around age 18.

Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.

UA scientist identifies cellular gene signatures for heart muscle regeneration
A research team led by Jared Churko, PhD, director of the University of Arizona iPSC Core in the UA Sarver Heart Center, used a transcriptomic approach -- studying what genes are expressed -- to identify gene signatures of cell subpopulations identified as atrial-like or ventricular-like.

Read More: Heart Muscle News and Heart Muscle Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.